CLR-121225

N/A

Report date: 2025/10/29 10:33:37

NME

Base Information

Drug NameCLR-121225

Drug Alias Namealpha-emitting phospholipid ether radiotherapeutic conjugate (Cellectar Biosciences)CLR-121225CLR 121225225 Ac-CLR 121225

ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Nuclides > Actinium > 225AcRadiation-emitting products > Radioactive therapeutic agent +[4]

Mechanisms of ActionIonising radiation emitters

TargetsUpdating

Therapy Area/IndicationsPancreatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCellectar Biosciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesCellectar Biosciences Inc

Inactive CompaniesN/A

Active IndicationsPancreatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A